Pfizer Course Has 23% Efficacy Vs. Omicron in S. African Study
South Africa in the news: Pfizer Course Has 23% Efficacy Vs. Omicron in S. African Study: Researchers at the Africa Health Research Institute in Durban issued additional data on a small study released earlier this week.: “South Africa” – BingNews Omicron spreads faster, reduces vaccine efficacy: WHO: The Omicron coronavirus variant appears to be more …
